Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Association between the APOE*4 allele and atherosclerosis is age dependent among Argentine males.

Bañares VG, Peterson G, Aguilar D, Gulayin R, Sisu E, Wyszynski DF, Pivetta OH, Tavella MJ.

Hum Biol. 2005 Apr;77(2):247-56.

PMID:
16201140
2.

APOE -491 T allele may reduce the risk of atherosclerotic lesions among middle-aged women.

Bañares VG, Bardach A, Peterson G, Tavella MJ, Schreier LE.

Mol Cell Biochem. 2012 Mar;362(1-2):123-31. doi: 10.1007/s11010-011-1134-5. Epub 2011 Nov 22.

PMID:
22101914
3.

Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study.

Ilveskoski E, Perola M, Lehtimäki T, Laippala P, Savolainen V, Pajarinen J, Penttilä A, Lalu KH, Männikkö A, Liesto KK, Koivula T, Karhunen PJ.

Circulation. 1999 Aug 10;100(6):608-13.

4.

[APOE-219g/T polymorphism related to serum lipid levels in atherosclerotic patients from Argentina].

Bañres V, Wyszynski D, Schreier L, Tavella M.

Invest Clin. 2010 Mar;51(1):17-26. Spanish.

PMID:
20815153
5.

Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.

Scaglione L, Bergerone S, Gambino R, Imazio M, Macchia G, Cravetto A, Gaschino G, Baralis G, Rosettani E, Pagano G, Cassader M.

Nutr Metab Cardiovasc Dis. 1999 Jun;9(3):118-24.

PMID:
10464784
6.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
7.

Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.

Güz G, Nurhan Ozdemir F, Sezer S, Işiklar I, Arat Z, Turan M, Haberal M.

Am J Kidney Dis. 2000 Oct;36(4):826-36.

PMID:
11007687
8.

Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.

Tascilar N, Dursun A, Ankarali H, Mungan G, Sumbuloglu V, Ekem S, Bozdogan S, Baris S, Aciman E, Cabuk F.

J Neurol Sci. 2009 Feb 15;277(1-2):17-21. doi: 10.1016/j.jns.2008.09.034. Epub 2008 Oct 21.

PMID:
18945448
9.

A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy.

Schmidt S, Klaver C, Saunders A, Postel E, De La Paz M, Agarwal A, Small K, Udar N, Ong J, Chalukya M, Nesburn A, Kenney C, Domurath R, Hogan M, Mah T, Conley Y, Ferrell R, Weeks D, de Jong PT, van Duijn C, Haines J, Pericak-Vance M, Gorin M.

Ophthalmic Genet. 2002 Dec;23(4):209-23.

PMID:
12567264
10.

Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.

Setzer M, Hermann E, Seifert V, Marquardt G.

Spine (Phila Pa 1976). 2008 Mar 1;33(5):497-502. doi: 10.1097/BRS.0b013e3181657cf7.

PMID:
18317192
11.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

12.

Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.

Lehtimäki T, Moilanen T, Viikari J, Akerblom HK, Ehnholm C, Rönnemaa T, Marniemi J, Dahlen G, Nikkari T.

J Lipid Res. 1990 Mar;31(3):487-95.

13.

Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.

Ferreira CN, Carvalho MG, Fernandes AP, Lima LM, Loures-Valle AA, Dantas J, Janka Z, Palotás A, Sousa MO.

Neurochem Int. 2010 Jan;56(1):177-82. doi: 10.1016/j.neuint.2009.09.016. Epub 2009 Oct 9.

PMID:
19819279
14.

Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.

Akanji AO, Ohaeri JU, Al-Shammri SN, Fatania HR.

Neuropsychobiology. 2009;60(2):67-72. doi: 10.1159/000236446. Epub 2009 Sep 10.

PMID:
19752580
15.

Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations.

Mella JG, Schirin-Sokhan R, Rigotti A, Pimentel F, Villarroel L, Wasmuth HE, Sauerbruch T, Nervi F, Lammert F, Miquel JF.

J Lipid Res. 2007 Jun;48(6):1378-85. Epub 2007 Mar 24.

16.

Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.

Lehtimäki T, Porkka K, Viikari J, Ehnholm C, Akerblom HK, Nikkari T.

Pediatrics. 1994 Oct;94(4 Pt 1):489-93.

PMID:
7936857
17.

Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.

Wang C, Zhou X, Ye S, Han D, Tan X, Zheng F, Shi Q.

Int J Hyg Environ Health. 2006 May;209(3):265-73. Epub 2006 Feb 3.

PMID:
16459141
18.

Association between apolipoprotein E alleles and calcific valvular heart disease.

Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP.

Circulation. 2003 Oct 14;108(15):1804-8. Epub 2003 Oct 6.

19.

Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease.

Nassar BA, Dunn J, Title LM, O'Neill BJ, Kirkland SA, Zayed E, Bata IR, Cantrill RC, Johnstone J, Dempsey GI, Tan MH, Breckenridge WC, Johnstone DE.

Clin Biochem. 1999 Jun;32(4):275-82.

PMID:
10463820
20.

Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia.

Siváková D, Zacharová M, Gasparovic J, Raslová K, Wsólová L, Basistová Z, Blazícek P.

Coll Antropol. 2006 Jun;30(2):387-94.

PMID:
16848156

Supplemental Content

Support Center